Category

News

Nicolab at ESNR 2021

By | News
We are very excited to be attending the 44th ESNR Annual Meeting in Geneva
29 September – 3 October

Come visit us at our booth in the main hall where we can give you a personal live demo and answer any questions you might have.

We have 7 Nicolab members attending over the course of the congress who all look forward to welcoming you!

Please feel free to pre-book a meeting or come and say hello.

Merel Boers

CEO

Eelco Dolfsma

Marketing Manager

Alex Puiu, PhD

Country Manager - DACH

Nick Wilson

Marketing Manager UK & Ireland

Marieke Dijkema

Country Manager - Netherlands

Hakima Arratbi

Country Manager - DACH

Esperanza Lázaro Valero

Country Manager - Iberia

Want to schedule a meeting with one of our representatives at ESNR this year?

Get in touch!

    Our solution aims to integrate people and the processes from diagnosis to treatment planning. The broad portfolio of AI algorithms produces results in minutes that can be accessed through our fully certified diagnostic viewer, anytime and anyplace. To read more about what StrokeViewer can do for your clinic today, head to the StrokeViewer website.
    Go to StrokeViewer

    “I think it works brilliantly as a screening tool to alert the team that there is high suspicion of LVO. The communication gets everyone coordinated in a parallel fashion...”

    Dr. Albert Yoo, MD

    Medical Director at Texas Stroke Institute

    StrokeViewer Features

    Mobile miniPACS

    This mobile miniPACS is an extension to the familiar hospital PACS , enabling stroke experts to access analyzed patient scans within minutes, anywhere on their device.

    Seamless image sharing

    Rapid image exchange allows stroke experts to forward patient scans to the nearest intervention center with the click of a button, physicians can then plan for patient arrival.

    Certified Diagnostic Viewer

    The certified diagnostic viewer is a unique feature to StrokeViewer. This allows physicians to diagnose patients from their mobile device.

    3D Treatment Planning

    This feature is included in StrokeViewer LVO. It helps neurologists and radiologists visualize the brain vasculature and blood clot.

    Interventional neuroradiologists in particular have reported their use of the 3D Treatment Planning feature for selecting the micro catheters to use prior to patient arrival.

    “It can be really helpful in detecting distal occlusions, because the 3D Treatment Planning can make an occlusion more obvious especially when a vessel goes into another slice or in a different direction. It prevents you from mistaking an occlusion for a loop in the vessel”

    Dr. Bart Emmer, Ph.D.

    Interventional Neuroradiologist, Amsterdam UMC, Netherlands

    Nicolab at ESMINT 2021

    By | News
    We are very excited to be returning to our first physical conference this year
    13th ESMINT Congress in Nice
    8 – 10 September

    Come visit us at Booth number 3 in the main hall where we can give you a personal live demo and answer any questions you might have.

    4 Nicolab members look forward to welcoming you, please feel free to pre-book a meeting or come and say hello!

    Razmara Nizak

    Clinical Innovation Manager

    Matt Proctor

    Country Manager - UK

    Jeroen Pex

    Chief Commercial Officer

    Ivo Jansen

    Chief Medical Officer

    Want to schedule a meeting with one of our representatives at ESMINT this year?

    Get in touch!

      Our solution aims to integrate people and the processes from diagnosis to treatment planning. The broad portfolio of AI algorithms produces results in minutes that can be accessed through our fully certified diagnostic viewer, anytime and anyplace. To read more about what StrokeViewer can do for your clinic today, head to the StrokeViewer website.
      Go to StrokeViewer

      “I think it works brilliantly as a screening tool to alert the team that there is high suspicion of LVO. The communication gets everyone coordinated in a parallel fashion...”

      Dr. Albert Yoo, MD

      Medical Director at Texas Stroke Institute

      StrokeViewer Features

      Mobile miniPACS

      This mobile miniPACS is an extension to the familiar hospital PACS , enabling stroke experts to access analyzed patient scans within minutes, anywhere on their device.

      Seamless image sharing

      Rapid image exchange allows stroke experts to forward patient scans to the nearest intervention center with the click of a button, physicians can then plan for patient arrival.

      Certified Diagnostic Viewer

      The certified diagnostic viewer is a unique feature to StrokeViewer. This allows physicians to diagnose patients from their mobile device.

      3D Treatment Planning

      This feature is included in StrokeViewer LVO. It helps neurologists and radiologists visualize the brain vasculature and blood clot.

      Interventional neuroradiologists in particular have reported their use of the 3D Treatment Planning feature for selecting the micro catheters to use prior to patient arrival.

      “It can be really helpful in detecting distal occlusions, because the 3D Treatment Planning can make an occlusion more obvious especially when a vessel goes into another slice or in a different direction. It prevents you from mistaking an occlusion for a loop in the vessel”

      Dr. Bart Emmer, Ph.D.

      Interventional Neuroradiologist, Amsterdam UMC, Netherlands

      NICO.LAB raises AU$13 million in pre-IPO investment round

      By | News, Press Release, Uncategorized

      NICO.LAB has an end-to-end artificial intelligence solution, StrokeViewer, that helps physicians to provide stroke patients with the right treatment, in time.

      The MedTech scale-up NICO.LAB has just closed AU$13 million in a Pre-IPO round led by Canaccord Genuity Australia. Founded in 2015 following the renowned MR CLEAN trial in The Netherlands[1], NICO.LAB developed an end-to-end artificial intelligence solution, StrokeViewer, that ensures stroke patients recieve the right treatment as fast as possible. NICO.LAB believes connecting human and artificial intelligence will revolutionise emergency care.

      StrokeViewer is a clinical-decision support tool that combines artificial intelligence (AI) algorithms and a communication platform to help stroke experts make faster, well-informed treatment decisions. Even today, too many patients do not receive the right treatment on time. A recent study showed that receiving treatment 1 minute earlier results in 1.3 days of additional disability-free life and saves on average €309 of healthcare costs in the Netherlands [2]. Stroke incidence and associated costs are rising drastically due to an ageing population and increasingly unhealthy lifestyles. StrokeViewer allows physicians to diagnose patients remotely, on any mobile or desktop device at any time of day, helping hospitals to cope with the rise in stroke patients. The secure cloud-based infrastructure of the solution makes implementation straightforward, requiring no additional hardware.

      Since 2015, NICO.LAB has evolved from a group of academic researchers and physicians to an international team spanning 3 continents. NICO.LAB attracts top talent from across the world to their Amsterdam Headquarters where all technology and algorithms are developed. The year 2020 marked many milestones for NICO.LAB; they received both FDA clearance and US reimbursement (New Technology Add-on Payment) for StrokeViewer, entered new markets including the UK, Germany and Australia and proved the clinical impact of their solution on patient outcome.

      Merel Boers, NICO.LAB co-founder and CEO, “We have the absolute A-list of Australia’s leading institutional funds and family offices on board to back us in our mission. For many patients the right treatment comes too late… Together with our new partners and investors, we are on a mission to empower physicians worldwide to provide every patient with the right treatment, on time!”

      The newly raised funds will be used to accelerate the development of NICO.LAB’s artificial intelligence solutions as well as fund the international growth of the company, to help them achieve their mission of empowering physicians worldwide to provide patients with the right treatment, in time.

      About
      NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center in the Netherlands and has offices in Australia, Europe and the United States. An international team of researchers, developers and physicians connects human & artificial intelligence to empower physicians in emergency care with end-to-end solutions. StrokeViewer consists of a comprehensive set of tools to support the entire stroke workflow. Local availability of StrokeViewer functionality is subject to applicable CE marking, TGA and FDA approval (the actual status is on www.strokeviewer.nico-lab.com).

      [1] Fransen PS, Beumer D, Berkhemer OA, van den Berg LA, Lingsma H, van der Lugt A, van Zwam WH, van Oostenbrugge RJ, Roos YB, Majoie CB, Dippel DW; MR CLEAN Investigators. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. 2014 Sep 1;15:343. doi: 10.1186/1745-6215-15-343. PMID: 25179366; PMCID: PMC4162915.

      [2]van Voorst H, Kunz WG, van den Berg LA, et al Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the NetherlandsJournal of NeuroInterventional Surgery Published Online First: 21 January 2021. doi: 10.1136/neurintsurg-2020-017017

      NICO.LAB announces new partnership with AI Advance

      By | News

      NICO.LAB and AI Advance announced a new partnership that will revolutionise stroke care across Australia and New Zealand. AI Advance will be distributing StrokeViewer, an artificial intelligence solution that empowers physicians with the triaging, diagnosis and treatment decision making of patients in the emergency stroke setting.

       

      StrokeViewer is a clinical-decision support tool that combines artificial intelligence (AI) algorithms and a communication platform to help stroke experts make faster well-informed treatment decisions. StrokeViewer allows physicians to diagnose stroke patients remotely, on any mobile or desktop device. The secure cloud-based infrastructure of the solution makes implementation straightforward, requiring no additional hardware. Hospitals across Australia and New Zealand, including those with minimal infrastructure, can implement StrokeViewer and raise their standard of stroke care.

      Jeroen Pex, Chief Commercial Officer at NICO.LAB: “AI Advance brings a long experience in the medical field and large network to the table, enabling NICO.LAB to hit the ground running in Australia and New Zealand. Their focus on AI solutions, makes them the right partner for us and for the hospitals and clinics in Australia and New Zealand.”

      Peter Rady, Director and Co-Founder of AI Advance (Australia): “I am really excited to bring StrokeViewer to the Australian market. As a country we are leading with mobile stroke treatment which is attracting government investment to reduce the time to treatment of stroke patients. I am proud that StrokeViewer can further support this strategy.”

      Stroke is a time-critical disease and third-biggest killer worldwide. During a stroke two million brain cells die every minute until blood flow is restored [1] therefore starting treatment earlier can make the difference between recovery or life-long disability. In Australia, every 19 minutes a patient suffers from a stroke. There are an estimated 450,000 stroke survivors living in the community, needing daily care[2]. Over half of all stroke survivors need some form of care. Besides the devastating effects on people’s lives, the economic burden in Australia in 2020 was over $6.2 billion[2].

      The TGA and Medsafe cleared algorithms are embedded in a cloud-based infrastructure. Medical specialists are notified of the AI results on their smartphone within minutes of the patient being scanned. The physicians are then able to inspect the CT images via a certified diagnostic viewer and diagnose a patient remotely or at the hospital.

      References:
      [1]Saver, 2006 – “Time is brain—quantified.” Stroke 37.1 (2006): 263-266

      [2]https://strokefoundation.org.au/News/2020/11/04/02/57/No%20Postcode%20Untouched#:~:text=An%20estimated%2027%2C428%20Australians%20experienced,stroke%20living%20in%20the%20community.

      Merel Boers CEO & Founder

      An introduction to our CEO, Dr. Merel Boers

      By | News

      NICO.LAB’s CEO, Dr. Merel Boers co-founded the company in 2015 following the groundbreaking MR CLEAN trial. The first Randomized Clinical Trial that proved the benefit of Endovascular Treatment which led to a paradigm shift in acute stroke care and triaging.

      Merel is an ambitious and inspiring entrepreneur as well as an innovative researcher. At a very young age Merel is driving NICO.LAB to internationalisation and great success.

       

      Merel gained a huge amount of knowledge through her PhD in stroke imaging that led her to obtaining one of the highest honours, summa cum laude, in her research at the University of Twente. During her PhD working at the Academic Medical Center, Amsterdam, Merel and her research colleague, Renan Sales-Barros (co-founder and Chief Technology Officer of NICO.LAB) identified the opportunity and need to improve care for such a time critical disease.

      NICO.LAB at ISC 2021

      By | News

      Our cloud-based solution enables physicians to provide every stroke patient with the right treatment in time.

      With Medicare Reimbursement, ICD-10-PCS code, we can help your hospital to improve patient outcome while reducing hospital costs

      StrokeViewer helps to reduce undetected LVOs

      • Artificial intelligence detects occlusions up to distal M2 on CTA
      • User immediately notified of findings via App/email
      • Automated PDF reports

      “I think it works brilliantly as a screening tool to alert the team that there is high suspicion of LVO. The communication gets everyone coordinated in a parallel fashion...”

      Dr. Albert Yoo, MD

      Medical Director at Texas Stroke Institute

      Want to schedule a meeting with Merel, our CEO or one of our Country Managers?

      Get in touch!

        StrokeViewer Features

        Mobile miniPACS

        This mobile miniPACS is an extension to the familiar hospital PACS , enabling stroke experts to access analyzed patient scans within minutes, anywhere on their device.

        Seamless image sharing

        Rapid image exchange allows stroke experts to forward patient scans to the nearest intervention center with the click of a button, physicians can then plan for patient arrival.

        Certified Diagnostic Viewer

        The certified diagnostic viewer is a unique feature to StrokeViewer. This allows physicians to diagnose patients from their mobile device.

        3D Treatment Planning

        This feature is included in StrokeViewer LVO. It helps neurologists and radiologists visualize the brain vasculature and blood clot.

        Interventional neuroradiologists in particular have reported their use of the 3D Treatment Planning feature for selecting the micro catheters to use prior to patient arrival.

        “It can be really helpful in detecting distal occlusions, because the 3D Treatment Planning can make an occlusion more obvious especially when a vessel goes into another slice or in a different direction. It prevents you from mistaking an occlusion for a loop in the vessel”

        Dr. Bart Emmer, Ph.D.

        Interventional Neuroradiologist, Amsterdam UMC, Netherlands

        New Paper Quantifying the Health and Cost Effects of Faster EVT

        By | News

        Currently 20% of LVOs are initially undetected1 and 40% of patients are treated too late2.

        At NICO.LAB we are working hard to ensure we help hospitals to reduce this % and streamline the workflow to reduce door to groin puncture time. It is extremely rewarding to read a paper with powerful numbers that actually quantifies the impact it has on a patient when just one minute is saved.

        The main conclusion from the paper is that EVT administered 1 minute faster results in overall healthcare cost savings on average of €309 and 1.3 days of disability free life in the Netherlands. Those numbers for an hour faster treatment translate to €18, 540 euro and 80 days on average.

        Click here to read the full paper from the MR CLEAN Registry titled Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the Netherlands3

         

        Authors: 

        Henk van Voorst,Wolfgang G Kunz,Lucie A van den Berg,Manon Kappelhof,Floor M E Pinckaers,Mayank Goyal,Myriam G M Hunink,Bart Emmer,Maxim Johan Heymen Laurence Mulder,Diederik W J Dippel,J M Coutinho,Henk A Marquering,Hieronymus D Boogaarts,Aad van der Lugt,Wim H van Zwam,Yvo B W E M Roos,Erik Buskens,Marcel G W Dijkgraaf,Charles B L M Majoie

         

        Publication: 

        Journal of NeuroInterventional Surgery

         

        Publisher:

        BMJ Publishing Group Ltd.

         

        Date:

        Jan 21, 2021

         

        References:
        1: B. Fasen, R. Kwee et al. AJNR 2020
        2: Kunz, W. G., et al. “Lifetime quality of life and cost consequences of treatment delays in endovascular thrombectomy for stroke.” BMJ 10 (2019)
        3: van Voorst H, Kunz WG, van den Berg LA, et al Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the NetherlandsJournal of NeuroInterventional Surgery Published Online First: 21 January 2021. doi: 10.1136/neurintsurg-2020-017017

        Generating brain CT images using Disentangled Variational Autoencoders

        By | News

        Can we generate CT slices of a brain? Or interpolate between two different brains? Or… if we represent the brain image as a set of numbers, can we change brain size, rotation, anatomy just by tweaking these numbers?

        I asked these questions when I first read the paper about Disentangled Variational Autoencoders (β-VAE).

        According to the paper, you can encode an image into a small numerical vector in a way that each vector’s variable will be responsible for one independent and interpretable visual feature. For faces, it can be skin color, age, gender, or image saturation. What these features will be for brain images? Let’s find out.

        Elena, one of our Machine Learning Engineers, shares a paper based on her recent research looking into whether neural networks can understand brain anatomy, maybe just a tiny bit?! Elena tries to answer this question using Disentangled Variational Autoencoder trained on brain CT slices.

        Request the full text below and a downloadable version will be sent via email.

          Cookies helpen ons om inzicht in het gebruik van deze website te krijgen. Meer informatie

          We gebruiken Google Analytics om inzicht te krijgen in het globale gebruik van deze website. We kunnen niet zien wie u bent, we kunnen alleen (anonieme) individuele gebruikers onderscheiden om te zien wie wat doet en wie bijvoorbeeld terugkomt op de website.

          Sluiten